My Portfolio

Regencell Bioscience Holdings Ltd RGC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 06/02/26 EDT

23.75

+0.60 (+2.59%)

Volume

92,653

52 week range

9.39 - 83.60

Open23.46
Day High25.14
Day Low23.25
Prev Close23.75
52 Week High83.60
52 Week High Date06/16/25
52 Week Low9.39
52 Week Low Date07/02/25

Latest On Regencell Bioscience Holdings Ltd

Stocks making biggest moves midday: GXO Logistics, CarMax, Nvidia and moreJune 20, 2025CNBC.com
Stocks making biggest moves premarket: CarMax, Darden Restaurants and moreJune 20, 2025CNBC.com
Stocks making the biggest moves midday: Nucor, Sunrun, Affirm, Circle and moreJune 18, 2025CNBC.com
Stocks making the biggest moves premarket: Sunrun, Korn Ferry, Oracle and moreJune 18, 2025CNBC.com
The prospect of an Israel-Iran ceasefire dims as Trump weighs strikesJune 18, 2025CNBC.com
Trump's social media posts crush hopes of an Israel-Iran ceasefire June 17, 2025CNBC.com
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000%June 17, 2025CNBC.com

Key Stats

Market Cap11.768B
Shares Out495.47M
10 Day Average Volume0.09M
Dividend-
Dividend Yield-
Beta1.66

Latest On Regencell Bioscience Holdings Ltd

Stocks making biggest moves midday: GXO Logistics, CarMax, Nvidia and moreJune 20, 2025CNBC.com
Stocks making biggest moves premarket: CarMax, Darden Restaurants and moreJune 20, 2025CNBC.com
Stocks making the biggest moves midday: Nucor, Sunrun, Affirm, Circle and moreJune 18, 2025CNBC.com
Stocks making the biggest moves premarket: Sunrun, Korn Ferry, Oracle and moreJune 18, 2025CNBC.com
The prospect of an Israel-Iran ceasefire dims as Trump weighs strikesJune 18, 2025CNBC.com
Trump's social media posts crush hopes of an Israel-Iran ceasefire June 17, 2025CNBC.com
Nasdaq-traded Chinese herb stock with no revenues rallies 59,000%June 17, 2025CNBC.com

KEY STATS

Open23.46
Day High25.14
Day Low23.25
Prev Close23.75
52 Week High83.60
52 Week High Date06/16/25
52 Week Low9.39
52 Week Low Date07/02/25
Market Cap11.768B
Shares Out495.47M
10 Day Average Volume0.09M
Dividend-
Dividend Yield-
Beta1.66

RATIOS/PROFITABILITY

EPS (TTM)-0.01
P/E (TTM)-1,660.84
Fwd P/E (NTM)-
EBITDA (TTM)-7.133M
ROE (TTM)-177.66%
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Regencell Bioscience Raises $20 Million in Registered Direct Offering Led by New Institutional InvestorMay 22, 2026TipRanks
Regencell Bioscience Raises $20 Million in Registered Direct Share OfferingMay 19, 2026TipRanks
RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Securities Class Action – Contact Levi & KorsinskyMay 13, 2026TipRanks
Regencell Bioscience Posts Higher Losses in First-Half 2026 Results Filed on Form 6-KMay 8, 2026TipRanks
Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation DisclosuresMay 6, 2026TipRanks

Profile

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Address

11/F First Commercial Building

33-35 Leighton Roa

999077

Hong Kong

https://www.regencellbioscience.com/